Fortress Biotech, Helocyte have announced the dosing of the first subject in the trial of Triplex for individuals who are ...

Valneva has announced positive outcomes from its Phase III VLA1553-321 trial of the single-shot IXCHIQ chikungunya virus ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...